User manual

62
5. What is the FDA doing to find out more about the possible health effects of
wireless phone RF?
The FDA is working with the U.S. National Toxicology Program and with groups of
investigators around the world to ensure that high-priority animal studies are conducted to
address concerns about the effects of exposure to Radio Frequency (RF) energy.
The FDA has been a leading participant in the World Health Organization International
Electro Magnetic Fields (EMF) Project since its inception in 1996. An influential result of
this work has been the development of a detailed agenda of research needs that has
implemented new research programs around the world. The project has also resulted in a
series of public information documents on EMF issues. The FDA and the Cellular
Telecommunications & Internet Association (CTIA) have a formal Cooperative Research
and Development Agreement (CRADA) to conduct research on wireless phone safety. The
FDA provides the scientific oversight, obtaining input from experts in government, industry,
and academic organizations. CTIA-funded research is conducted through contracts with
independent investigators. The initial research will include both laboratory studies and
studies of wireless phone users. The CRADA will also include a broad assessment of
additional research needs in the context of the latest research developments around the
world.
6. What research is needed to decide whether RF exposure from wireless phones
poses a health risk?
A combination of laboratory studies and epidemiological studies of people actually using
wireless phones would provide some of the vital data. Lifetime animal exposure studies
could be completed in a few years. However, very large numbers of animals would be
needed to provide reliable proof of a cancer-promoting effect, if one exists. Epidemiological
studies can provide data that is directly applicable to human populations, but ten or more